12 Results for "

human nicotinamide phosphoribosyltransferase

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "human nicotinamide phosphoribosyltransferase" in MCE Product Catalog:

  • Targets Recommended:
6
6 Cited Publications
Cat. No.: HY-P70353
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: NAMPT; Pre-B-Cell Colony-Enhancing Factor 1; Prev. PBEF1; Pre-B-Cell Colony Enhancing Factor 1; Visfatin; 1110035O14Rik; PBEF; Nampt; NAmPRTase; VF; nicotinamide phosphoribosyltransferase; Pre-B Cell-Enhancing Factor
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-14373
CAS No.: 206275-15-2
Purity:  98.75%
Synonyms: ZM 242421
Target:  

NAMPT

Research Areas:  

Cancer

CB30865 (ZM 242421) is a nicotinamide phosphoribosyltransferase (Nampt) inhibitor, with potent cytotoxicity. CB30865 is highly potent against a variety of human tumour cell lines (IC50 values in the 1-10 nM range) . CB30865 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-163280
CAS No.: 3011930-28-9
Research Areas:  

Neurological Disease

JGB-1-155 is a nicotinamide phosphoribosyltransferase (NAMPT) activator and also a reactive oxygen species (ROS) inhibitor. JGB-1-155 binds to NAMPT, thereby enhancing its catalytic activity and increasing intracellular NAD + levels. JGB-1-155 alleviates the elevation of ROS levels induced by various types of damage. JGB-1-155 can be used in research related to neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-162537
CAS No.: 2484876-99-3
Target:  

PROTACs NAMPT

Research Areas:  

Cancer

LYP-8 is an intracellular nicotinamide phosphoribosyltransferase (iNAMPT) PROTAC degrader with an IC50 of 0.76 μM. LYP-8 recruits VHL E3 ligase to induce iNAMPT polyubiquitination and proteasome-dependent degradation, and inhibits iNAMPT enzymatic activity. LYP-8 reduces eNAMPT levels by degrading iNAMPT to decrease eNAMPT secretion. LYP-8 reduces intracellular NAD + levels in cancer cells and proinflammatory cytokine levels (IL-6, TNF-α) in tumor tissue and serum. LYP-8 can be used for the research of colon cancer .
loading...
    loading...
Cat. No.: HY-182567
CAS No.: 2109805-79-8
Target:  

NAMPT

Research Areas:  

Cancer

Nampt-IN-19 is an orally active and non-substrate nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with a human Ki of 5.6 nM. Nampt-IN-19 blocks NAD + biosynthesis from Nicotinamide (HY-B0150). Nampt-IN-19 acts as an antiproliferative agent in cancer cells. Nampt-IN-19 has preclinical pharmacokinetic properties supporting oral antitumor activity in mouse xenograft models. Nampt-IN-19 can be used for the research of colorectal cancer .
loading...
    loading...
Cat. No.: HY-189001
Target:  

NAMPT PROTECs

Research Areas:  

Cancer

PROTEC NAMPT Degrader-1 is a NAMPT PROTEC degrader. PROTEC NAMPT Degrader-1 binds to NAMPT via non-covalent interactions and degrades this protein through a proximity-induced radical oxidation mechanism mediated by cyclopropane radical clock, independent of proteasomal or lysosomal pathways. PROTEC NAMPT Degrader-1 exhibits anticancer activity against ovarian cancer. It can be used in relevant studies on ovarian cancer (Pink: NAMPT ligand: (HY-188123); Linker: (HY-188124)) .
loading...
    loading...
Cat. No.: HY-187360
CAS No.: 3087291-81-1
Research Areas:  

Others

MC-Val-Ala-PAB-NH-Ph-CO-piperidin-4-ol-C4-NH-cyanoguanidine is a cathepsin B-cleavable linker-payload, with Nampt-IN-22 (HY-187336) as its toxin moiety. MC-Val-Ala-PAB-NH-Ph-CO-piperidin-4-ol-C4-NH-cyanoguanidine can be used for the synthesis of ADC .
loading...
    loading...
Cat. No.: HY-184247
CAS No.: 2791469-14-0
Target:  

NAMPT

SR-32685 is a NAMPT activator and neuroprotective agent. SR-32685 enhances the enzymatic activity of hNAMPT, prevents intracellular NAD depletion, and protects neurons from death induced by toxic misfolded prion proteins. SR-32685 can be used in the research of protein misfolding neurodegenerative diseases and metabolic diseases .
loading...
    loading...
Cat. No.: HY-P704014
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: NAMPT; Pre-B-Cell Colony-Enhancing Factor 1; Prev. PBEF1; Pre-B-Cell Colony Enhancing Factor 1; Visfatin; 1110035O14Rik; PBEF; Nampt; NAmPRTase; VF; nicotinamide phosphoribosyltransferase; Pre-B Cell-Enhancing Factor
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-184246
CAS No.: 2791469-19-5
Target:  

NAMPT

Research Areas:  

Neurological Disease

SR-34831 is a NAMPT activator, NAD level stabilizer and neuroprotective agent. SR-34831 enhances the enzymatic activity of human NAMPT, prevents intracellular NAD depletion, and counteracts neuronal death induced by toxic misfolded prion proteins. SR-34831 exhibits metabolic stability in human liver microsomes and can be used for the research of protein misfolding neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-181350
CAIX/XII/NAMPT-IN-1 is a triple inhibitor of carbonic anhydrase IX/XII and nicotinamide phosphoribosyltransferase (NAMPT) with a hCA IX Ki of 78.1 nM, hCA XII Ki of 64.4 nM, and hNAMPT IC50 of 168 nM. CAIX/XII/NAMPT-IN-1 induces apoptosis, ROS accumulation, suppresses ERK/AKT signaling, inhibits DNA synthesis, and causes mitochondrial dysfunction. CAIX/XII/NAMPT-IN-1 exerts antiproliferative effects against multiple cancer cells under normoxic and hypoxic conditions. CAIX/XII/NAMPT-IN-1 can be used for the research of cancer, such as renal carcinoma, glioblastoma and colorectal cancer .
loading...
    loading...
Cat. No.: HY-184467
CAS No.: 1362150-16-0
Target:  

NAMPT

Research Areas:  

Cancer

Nampt-IN-20 is a nicotinamide phosphoribosyltransferase (Nampt) inhibitor with a IC50 of 9.0 nM. Nampt-IN-20 binds to the active site of Nampt, occupies the NAM-binding region and disrupts NAD biosynthesis. Nampt-IN-20 exerts antiproliferative effects in A2780 ovarian cancer cells. Nampt-IN-20 can be used for the research of ovarian cancer .
loading...
    loading...
  • 1